SeaStar Medical Holding Corp. Files 8-K

TL;DR

SeaStar Medical Holding Corp. filed an 8-K on Aug 20, 2024, signaling a material definitive agreement.

AI Summary

SeaStar Medical Holding Corp. entered into a material definitive agreement on August 20, 2024. The company, formerly known as LMF Acquisition Opportunities Inc., is incorporated in Delaware and operates in the surgical and medical instruments sector. This filing is a current report on Form 8-K.

Why It Matters

This filing indicates a significant event for SeaStar Medical Holding Corp., potentially related to a new agreement that could impact its business operations and financial standing.

Risk Assessment

Risk Level: medium — Form 8-K filings often signal significant corporate events, which can introduce volatility and uncertainty for investors.

Key Numbers

• 001-39927 — SEC File Number (Identifies the company's filing with the SEC.)
• 85-3681132 — IRS Number (Company's Employer Identification Number.)

Key Players & Entities

• SeaStar Medical Holding Corp. (company) — Registrant
• LMF Acquisition Opportunities Inc. (company) — Former company name
• August 20, 2024 (date) — Date of earliest event reported
• 3841 (sic_code) — Standard Industrial Classification for Surgical & Medical Instruments & Apparatus

FAQ

Key Financial Figures

• $0.0001 — ich registered Common Stock par value $0.0001 per share ICU The Nasdaq Stock Mark
• $11.50 — sable for one share of Common Stock for $11.50 per share ICUCW The Nasdaq Stock Ma
• $25 million — s having an aggregate offering price of $25 million was filed with the SEC on the date here

Filing Documents

• ea0211858-8k_seastar.htm (8-K) — 38KB
• ea021185801ex5-1_seasta.htm (EX-5.1) — 6KB
• ea021185801ex10-1_seasta.htm (EX-10.1) — 226KB
• ex5-1_001.jpg (GRAPHIC) — 9KB
• 0001213900-24-071230.txt ( ) — 559KB
• icu-20240820.xsd (EX-101.SCH) — 4KB
• icu-20240820_def.xml (EX-101.DEF) — 26KB
• icu-20240820_lab.xml (EX-101.LAB) — 36KB
• icu-20240820_pre.xml (EX-101.PRE) — 25KB
• ea0211858-8k_seastar_htm.xml (XML) — 6KB

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement On August 20, 2024, SeaStar Medical Holding Corporation, a Delaware corporation (the "Company") entered into an At The Market Offering Agreement (the "ATM Agreement") with H.C. Wainwright & Co., LLC, as sales agent ("Wainwright"), to sell shares of its common stock, par value $0.0001 per share (the "Shares") from time to time, through an "at the market offering" program under which Wainwright will act as sales agent. The sales, if any, of the Shares made under the ATM Agreement will be made by any method permitted by law deemed to be an "at the market offering" as defined in Rule 415 promulgated under the Securities Act of 1933, as amended (the "Securities Act"), including sales made directly on or through the Nasdaq Capital Market or on any other existing trading market for the Company's common stock. The Company will pay Wainwright a commission rate equal to 3.0% of the aggregate gross sales price from the sales of Shares pursuant to the ATM Agreement and has agreed to provide Wainwright with customary indemnification and contribution rights against certain liabilities, including liabilities under the Securities Act. The Company will also reimburse Wainwright for certain specified expenses in connection with entering into the ATM Agreement, including certain fees and out-of-pocket expenses of its legal counsel. The ATM Agreement contains customary representations and warranties and conditions to the sale of the Shares pursuant thereto. The Company is not obligated to sell any of the Shares under the ATM Agreement and may at any time upon ten business days' prior notice suspend solicitation and offers thereunder. No assurance can be given that the Company will sell any Shares under the ATM Agreement, or if the Company does, as to the price or amount of Shares that the Company will sell, or the dates on which any such sales will take place. The offering of Shares pursuant to the ATM Agreement will terminate on

01 Financial

Item 9.01 Financial (d) Exhibits Exhibit No. Description 5.1 Opinion of Dorsey & Whitney LLP dated August 20 , 2024 10.1 At The Market Offering Agreement, dated August 20, 2024, by and between SeaStar Medical Holding Corporation, and H.C. Wainwright & Co., LLC 23.1 Consent of Dorsey & Whitney LLP (included in Exhibit 5.1) 104 Cover Page Interactive Data File - the cover page iXBRL tags are embedded within the Inline XBRL document 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SeaStar Medical Holding Corporation By: /s/ Eric Schlorff Date: August 20, 2024 Name: Eric Schlorff Title: Chief Executive Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR